Dr Andres Martinez

Spesialisasi: Rheumatologist
17 tahun pengalaman
Berbahasa:
English, Spanish
Konsultasi online: tersedia
Tempat kerja: Colômbia, Medellín, Stem Cells Colombia
Dual specialist in Internal Medicine (2020) and Rheumatology (2023), with Colombian MEN convalidation (2023–2024).
Dr. Andres Martinez is a physician. He specializes in Internal Medicine (UBA, 2020; MEN validation, 2023) and in Rheumatology (UBA/SAR, 2023; MEN validation, 2024). He earned his MD from Universidad Militar Nueva Granada in 2009.

He is a Rheumatology specialist at BIOMAB, Bogotá (Nov 2024–present). He previously worked at SIES Salud, Cúcuta (Dec 2023–Mar 2025) and Centros Médicos Sanitas, Villavicencio (Apr–Jul 2025). He completed Rheumatology training at Hospital Bernardino Rivadavia (2020–2023). He finished an Internal Medicine residency at Sanatorio Franchin (2016–2020).

His background includes emergency and primary care roles across Colombia (2010–2015). He also served as a sub-investigator in a dengue vaccine study (2013).

Konsultasi online dengan Dr Andres Martinez

Mudah dan praktis

100% aman dan rahasia

$100

Bagaimana pelayanan kami?

1 dari 3

Informasi tentang dokter ini lengkap dan jelas.

Sangat tidak setuju

Sangat setuju

Kualifikasi

Education & Certification

• MD, Universidad Militar Nueva Granada, Bogotá (Jun 2009).

• Specialist — Internal Medicine (UBA; completion Sep 2020; convalidation MEN Sep 2023).

• Specialist — Rheumatology (UBA/SAR; completion Aug 2023; convalidation MEN Jun 2024).

Clinical Experience

• BIOMAB, Bogotá — Specialist in Rheumatology (Nov 01, 2024 – present).

• SIES Salud, Cúcuta — Specialist in Rheumatology (Dec 01, 2023 – Mar 2025). • Centros Médicos Sanitas, Villavicencio — Specialist in Rheumatology (Apr 01, 2025 – Jul 30, 2025).

• Hospital Bernardino Rivadavia, Buenos Aires — Rheumatology training/consults (2020–2023).

• Sanatorio Franchin, Buenos Aires — Residency in Internal Medicine (2016–2020).

• Earlier roles: Emergency and primary care positions across Colombia (2010–2015); sub‑investigator in dengue vaccine study (2013).